Company Overview of Ciloa SAS
Ciloa SAS manufactures and distributes membrane protein and monoclonal antibody producing tools. The company offers drug, vaccine, diagnostic, and therapy development tools. It provides trans-membrane protein ligand screening and profiling; monoclonal antibody development and profiling; and diagnostic test, candidate therapeutic, and preventive vaccine development services. Ciloa SAS was founded in 2011 and is based in Montpellier, France.
cc 107 Bat. 24 , 2eme ét.
Universite Montpellier II
Place E. Bataillon
Founded in 2011
33 4 67 14 39 97
33 4 67 14 42 86
Key Executives for Ciloa SAS
Ciloa SAS does not have any Key Executives recorded.
Similar Private Companies By Industry
|Acticor Biotech SAS||Europe|
|Aelis Farma S.A.S.||Europe|
|Aenitis Technologies SAS||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
Sponsored Financial Commentaries
To contact Ciloa SAS, please visit www.ciloa.fr. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.